Insights into Inhibitors-FEIBA_Russia_Program Overview and Agenda_v8_4.pptx

FEIBA-The Inhibitor taking care agent

1. Insights into Inhibitors Sharing Knowledge – Advancing Care St. Petersburg, Russia 25 th – 26 th October 2019 Confidential - for internal use only

2. ‹#›

3. Time Topic/Title Speaker 4:30 Welcome TAKEDA 4:40 Executive Vision and New Horizons for Takeda Dina El Salmy , ICMEA Head of Portfolio Management 4:55 Chairman’s Welcome and the State of Care for Inhibitor Patients in Russia Dr. Tatiana Andreeva (Russia) 5:05 Guest Speaker (TBC) 5:20 Treatment of Inhibitors with Factor Replacement (working title) Dr Hans-Hermann Brackmann (Germany) 5:35 (Inhibitor Topic – “Scientific” background – inhibitors, and mechanism of FEIBA) Dr Cindy Leissinger (USA) 5:50 Q&A International Faculty (and Guest Speaker) Facilitated by Dr. Tatiana Andreeva 6:10 Closing Comments and Ready for Day 2 Dr. Tatiana Andreeva 6:15 Adjourn 7:15 Depart for group dinner (7:30-9:30) AGENDA: Day 1 – Friday, 25 October ‹#›

4. Time3 Topic/Title Speaker 8:30 Welcome and State of Care for Prophylaxis and ITI in Russia Dr. Nadezhda Zozulya PLENARY – FEIBA: Prophylaxis and ITI Facilitated by Dr Cindy Leissinger & Dr. Nadezhda Zozulya 8:40 (20 min) Topic 1 (Prophylaxis – scientific and clinical foundational presentation, PRO FEIBA) Dr Cindy Leissinger (USA) Dr Ashwani K Sood (India) 9:00 (20 min) Topic 2 (ITI – scientific and clinical foundational presentation) Dr Hans-Hermann Brackmann (Germany) 9:20 Facilitated Q&A: Prophylaxis and ITI Dr. Nadezhda Zozulya 9:35 Case Review Workshop Introduction and Breakout Facilitated by Dr Cindy Leissinger 9:40 Break 10:00 Case Reviews in Prophylaxis, ITI, and On Demand 3 breakout rooms 2 Faculty per room; FACULTY rotates at changeover Open with profiles and typical cases for FEIBA 3-4 unique and interesting cases discussed in depth in each room Rotations 10:00-10:50 10:50-11:40 11:40-12:30 All faculty from above 1. Dr Cindy Leissinger (USA) 2. Dr Hans-Hermann Brackmann (Germany) 3. Regional speaker (KSA/Turkey/Russia) 4. Dr. Tatiana Andreeva (Russia) 5. Dr Kaya (Turkey) 6. Dr. Bensadok (Algeria) 12:30 Lunch AGENDA: Day 2 – Saturday, 26 October (morning)

5. Meeting Approved on Promo mats ‹#› | Title | DD/MM/YY | Confidential - for internal use only

6. Time Topic/Title Speaker PLENARY – FEIBA and Surgery for Inhibitor Patients Dr. Tatiana Polyanskaya 13:30 (SURF Data) Dr Cindy Leissinger (USA) 13:50 Q&A Dr. Tatiana Polyanskaya 14:00 Case Review Workshops (All from above) 14:05 Case Reviews and Discussion: FEIBA in Surgery 5 case reviews to support specific patient types 2 breakout rooms 3 Faculty per room; FACULTY rotates at changeover 2 cases each per faculty in each room Use ARS to engage (tbd) Rotations 14:05-14:55 BREAK 15:20-16:10 1. Dr Cindy Leissinger (USA) 2. Dr. Tatiana Polyanskaya (Russia) 3. Dr Kaya (Turkey) 4. Regional speaker 5. Dr Kavakli (Turkey) 6. Dr. Brackmann (Facilitate) 16:15 Patient Services and Support for PwHA with Inhibitors Includes 3 country-specific examples of implementation and impact Dr Bensadok (Algeria) Dr. Inna Markova (Russia) 16:35 Foundations in Acquired Hemophilia A – Diagnosis and Treatment with FEIBA Dr Hans-Hermann Brackmann (Germany) 16:50 (New Horizons in the Treatment of AHA) Dr Cindy Leissinger (USA) 17:00 Q&A Dr. Tatiana Polyanskaya 17:15 Closing Comments Dr. Tatiana Polyanskaya Dina El Salmy AGENDA: Day 2 – Saturday, 26 October (afternoon)